News & Resources
-
Putting the Drug Debate into Context: the State of Pharmaceutical Cost Reform in the U.S.
U.S. medical care has experienced huge and unsustainable spending increases—especially in drug prices—for decades. Under the Affordable Care Act, the Obama administration accelerated the value-based care movement to address key spending categories such as hospital and physician care. Value-based purchasing seeks to reduce spending by improving quality and efficiency to address unnecessary costs. Most stakeholders … Continue reading “Putting the Drug Debate into Context: the State of Pharmaceutical Cost Reform in the U.S.”
-
The Need to Treat the Ailing U.S. Pharmaceutical Pricing System
Prescription drug prices in the U.S. have been rising at an alarming rate, contributing to the nation’s high health care costs. This concerns policy makers at the state and federal levels, prompting exploration of new options to get a better handle on costs while maintaining Americans’ access to pharmacological innovations. Putting Drug Prices into Context … Continue reading “The Need to Treat the Ailing U.S. Pharmaceutical Pricing System”
-
Radiological Accidents: The Surprising Physiological and Sociological Impacts
Fukushima. Chernobyl. Three Mile Island. Each is immediately recognizable for the radiological accident that wreaked havoc on plant workers and nearby residents. And while it’s true that nuclear disasters can and do cause devastation, the surprising reality is that the psychosocial impacts can vastly outweigh the physiological effects. “The sociological impacts can kill people,” says … Continue reading “Radiological Accidents: The Surprising Physiological and Sociological Impacts”
-
The ACA Is Still Alive and Still in Danger
Today the ACA is still alive. Donald Trump’s campaign boast that he would sign a bill repealing the Affordable Care Act (ACA/Obamacare) on his inauguration day is long gone and forgotten. House Speaker Paul Ryan and Senate Majority Leader Mitch McConnell’s gamble that by April 28th the ACA would be effectively decimated using the expedited … Continue reading “The ACA Is Still Alive and Still in Danger”
-
Exploring the Next Phase of Health Care Reform: How Health Care Leaders Can Position Their Organizations for Success
These are uncertain times in American health care. The Republican Congress and President Trump have vowed to repeal and replace the Patient Protection and Affordable Care Act (ACA), commonly called Obamacare. They recently unveiled the American Health Care Act, the replacement plan, which has met with substantial resistance from all parts of the political spectrum. … Continue reading “Exploring the Next Phase of Health Care Reform: How Health Care Leaders Can Position Their Organizations for Success”
-
Snapshot of the American Pharmaceutical Industry
The passage of the Affordable Care Act has been profitable for pharmaceutical companies in the U.S., with more Americans now having access to prescription drugs. But as this article explores, there are many complexities inherent in the drug industry that need to be addressed moving forward.
-
A Roadmap to Improve Customer-Centricity in Health Care
Healthcare lags behind in strategically engaging consumers. This article explores how health care organizations can engage in customer-driven strategies and improve customer centricity.
-
Staying Relevant in the Midst of Health Care Reform: A Primer for Healthcare Executives
Dr. John McDonough, Professor of Public Health Practice at Harvard T.H. Chan School of Public Health, discusses the Affordable Care Act, health reform, and the changing health care landscape.
-
Genomic Medicine in the Next Decade
The field of genomic medicine is only about 10 years old, said Gerardo Jimenez-Sanchez, a leading researcher in the field. Raju Kucherlapati, from Harvard Medical School’s department of genomics, adds, “The rate of accumulation of knowledge” is moving at an “ever increasing pace.” It’s clear that 10 to 15 years from now, genomic medicine will … Continue reading “Genomic Medicine in the Next Decade”
-
Genomic Medicine in the Real World: ‘Hope’ and ‘Hype’
Genomics has, in a remarkably short period of time, led to revelations across a wide range of scientific disciplines. It’s helped us better understand everything from cancer to dinosaurs to the intricacies of sexual selection. In medicine, the study of genomics is already saving lives and driving trillions of dollars of economic activity. The ability … Continue reading “Genomic Medicine in the Real World: ‘Hope’ and ‘Hype’”
-
Equipping Physicians To Manage The Rapidly Evolving World of Health Care
On Mother’s Day, 2003, 5-year-old Matthew Siravo, who had epilepsy, died at Boston Children’s Hospital, two days after suffering a seizure that lasted an hour and a half. Siravo’s story made headlines in the local news, and in September of that year, the Massachusetts Department of Public Health issued what The Boston Globe called “a … Continue reading “Equipping Physicians To Manage The Rapidly Evolving World of Health Care”
-
8 Challenges to Customer-Driven Health Care
Health care is increasingly driven by patients who are behaving more like consumers and customers as they seek the best care at the most affordable price. As the industry evolves—due to fierce cost pressures, the Affordable Care Act, advances in technology, a new emphasis on preventative care, health-system mergers, and a host of other factors—one … Continue reading “8 Challenges to Customer-Driven Health Care”